to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Rubin, David T.
One or more keywords matched the following items that are connected to
Rubin, David T.
Emerging Therapies for Inflammatory Bowel Disease.
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
The use of tofacitinib in the treatment of inflammatory bowel disease.
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.